BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8547322)

  • 1. Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung.
    Giaccone G; van Ark-Otte J; Scagliotti G; Capranico G; van der Valk P; Rubio G; Dalesio O; Lopez R; Zunino F; Walboomers J
    Biochim Biophys Acta; 1995 Dec; 1264(3):337-46. PubMed ID: 8547322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of DNA topoisomerase II alpha and II beta genes between small cell and non-small cell lung cancer.
    Syahruddin E; Oguri T; Takahashi T; Isobe T; Fujiwara Y; Yamakido M
    Jpn J Cancer Res; 1998 Aug; 89(8):855-61. PubMed ID: 9765623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression of DNA topoisomerases I, II alpha and II beta and response to cisplatin-based chemotherapy in advanced ovarian carcinoma.
    Cornarotti M; Capranico G; Bohm S; Oriana S; Spatti GB; Mariani L; Ballabio G; Zunino F
    Int J Cancer; 1996 Aug; 67(4):479-84. PubMed ID: 8759604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of DNA topoisomerase II alpha expression in small cell and nonsmall cell carcinoma of the lung. In search of a mechanism of chemotherapeutic response.
    Guinee DG; Holden JA; Benfield JR; Woodward ML; Przygodzki RM; Fishback NF; Koss MN; Travis WD
    Cancer; 1996 Aug; 78(4):729-35. PubMed ID: 8756364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer.
    Yan S; Shun-Chang J; Li C; Jie L; Ya-Li L; Ling-Xiong W
    BMC Cancer; 2010 Nov; 10():621. PubMed ID: 21067592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a polymerase chain reaction aided transcript titration assay (PATTY) for topoisomerase II in lung cancer samples.
    Dingemans AM; Van Ark-Otte J; Smit EF; Postmus PE; Giaccone G
    Anticancer Res; 2000; 20(5B):3549-54. PubMed ID: 11131661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous quantitation of topoisomerase II alpha and beta isoform mRNAs in lung tumor cells and normal and malignant lung tissue.
    Mirski SE; Voskoglou-Nomikos T; Young LC; Deeley RG; Campling BG; Gerlach JH; Cole SP
    Lab Invest; 2000 Jun; 80(6):787-95. PubMed ID: 10879730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher expression of topoisomerase II in lung cancers than normal lung tissues: different expression pattern from topoisomerase I.
    Hasegawa T; Isobe K; Nakashima I; Shimokata K
    Biochem Biophys Res Commun; 1993 Aug; 195(1):409-14. PubMed ID: 8395833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
    Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
    Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer.
    Dingemans AC; van Ark-Otte J; Span S; Scagliotti GV; van der Valk P; Postmus PE; Giaccone G
    Lung Cancer; 2001 May; 32(2):117-28. PubMed ID: 11325482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.
    Dingemans AM; Witlox MA; Stallaert RA; van der Valk P; Postmus PE; Giaccone G
    Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of the topoisomerase II alpha gene in a non-small cell lung cancer cell line and characterisation of polymorphisms at the human topoisomerase II alpha and beta loci in normal tissue.
    Keith WN; Tan KB; Brown R
    Genes Chromosomes Cancer; 1992 Mar; 4(2):169-75. PubMed ID: 1373318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and relationship between topoisomerase I and II alpha genes in tumor and normal tissues in esophageal, gastric and colon cancers.
    Kim R; Ohi Y; Inoue H; Toge T
    Anticancer Res; 1999; 19(6B):5393-8. PubMed ID: 10697567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon.
    Staley BE; Samowitz WS; Bronstein IB; Holden JA
    Mod Pathol; 1999 Apr; 12(4):356-61. PubMed ID: 10229499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase II alpha content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines.
    Yamazaki K; Isobe H; Hanada T; Betsuyaku T; Hasegawa A; Hizawa N; Ogura S; Kawakami Y
    Cancer Chemother Pharmacol; 1997; 39(3):192-8. PubMed ID: 8996519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevations of DNA topoisomerase I in transitional cell carcinoma of the urinary bladder: correlation with DNA topoisomerase II-alpha and p53 expression.
    Monnin KA; Bronstein IB; Gaffney DK; Holden JA
    Hum Pathol; 1999 Apr; 30(4):384-91. PubMed ID: 10208458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
    Withoff S; de Vries EG; Keith WN; Nienhuis EF; van der Graaf WT; Uges DR; Mulder NH
    Br J Cancer; 1996 Dec; 74(12):1869-76. PubMed ID: 8980384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced coexpression of YB-1 and DNA topoisomerase II alpha genes in human colorectal carcinomas.
    Shibao K; Takano H; Nakayama Y; Okazaki K; Nagata N; Izumi H; Uchiumi T; Kuwano M; Kohno K; Itoh H
    Int J Cancer; 1999 Dec; 83(6):732-7. PubMed ID: 10597187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of DNA topoisomerase I, DNA topoisomerase II alpha, p53, and Ki-67 in oral preneoplastic lesions and oral squamous cell carcinomas.
    Hafian H; Venteo L; Sukhanova A; Nabiev I; Lefevre B; Pluot M
    Hum Pathol; 2004 Jun; 35(6):745-51. PubMed ID: 15188142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance related genes and p53 expression in human non small cell lung cancer.
    Galimberti S; Marchetti A; Buttitta F; Carnicelli V; Pellegrini S; Bevilacqua G; Petrini M
    Anticancer Res; 1998; 18(4C):2973-6. PubMed ID: 9713494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.